Literature DB >> 18936566

Duodenal switch operative mortality and morbidity are not impacted by body mass index.

Henry Buchwald1, Todd A Kellogg, Daniel B Leslie, Sayeed Ikramuddin.   

Abstract

OBJECTIVE: This report examines the < or =30-day postoperative mortality and morbidity in our first 190 duodenal switch (DS) patients. BACKGROUND DATA: DS is the most weight loss effective and the most difficult to perform bariatric procedure. Indeed, certain surgeons have advocated a 2-stage approach to minimize complications, especially in the super obese (body mass index [BMI] > or =50 kg/m(2)).
METHODS: DS procedures were performed (n = 190) by either open (n = 168) or laparoscopic/robotic surgery in an academic setting: common channel 75 to 125 cm, sleeve gastrectomy (approximately 100 mL gastric pouch), closed duodenal stump, end-to-side duodenoileostomy hand-sewn in 2 layers, with most staple lines oversewn, and all mesentery defects closed.
RESULTS: For the 190 patients, 149 were female (78%) and the mean age was 43 years (range, 16-71). Mean preoperative weight 151.4 kg (range, 74.1-332.7); mean preoperative BMI 53.4 kg/m(2) (range, 32-107), with 100 (52.6%) of the patients super obese (BMI > or =50 kg/m(2)). Seventy-four patients had concurrent procedures, eg, cholecystectomy (n = 22), ventral or umbilical hernia repair (n = 19), and hiatus hernia repair (n = 10). Mean operating room time was 337 minutes (range, 127-771); mean hospitalization time was 6 days (range, 2-38). There were no deaths. Serious < or =30-day complications (n = 18 in 14 patients) consisted of 2 leaks (1.0%), which responded to drainage, and intra-abdominal bleeding (n = 3), splenectomy (n = 1), acute pancreatitis (n = 2), gastric outlet obstruction (n = 1), acute renal failure (n = 2), pneumonia (n = 2), respiratory failure (n = 3), acute myocardial infarction (n = 1), and duodenoileostomy stricture requiring endoscopic dilation (n = 1). The serious complication rate in patients with a BMI <50 kg/m(2) was 6.7% (6 of 90) and 12% (12 of 100) with a BMI > or =50 kg/m(2) (NS). Surgical site infections occurred in 7 patients with a BMI <50 kg/m(2) and in 12 with a BMI > or =50 kg/m(2) (NS). Overall complication rate in patients with a BMI <50 kg/m(2) was 14.4% (13 of 90) and 24% (24 of 100) with a BMI > or =50 kg/m(2) (NS).
CONCLUSIONS: With attention to careful surgical technique, DS can be performed relatively safely in the morbidly and super morbidly obese, and does not require a 2-stage procedure.

Entities:  

Mesh:

Year:  2008        PMID: 18936566     DOI: 10.1097/SLA.0b013e318188e1c2

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Revision of Roux-en-Y Gastric Bypass with Limb Distalization for Inadequate Weight Loss or Weight Regain.

Authors:  Reuben D Shin; Michael B Goldberg; Allison S Shafran; Samuel A Shikora; Melissa C Majumdar; Scott A Shikora
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

2.  Robotically-assisted laparoscopic biliopancreatic diversion with duodenal switch: the utility of the robotic system in bariatric surgery.

Authors:  Gintaras Antanavicius; Iswanto Sucandy
Journal:  J Robot Surg       Date:  2012-07-27

3.  Biliopancreatic diversion-duodenal switch: independent contributions of sleeve resection and duodenal exclusion.

Authors:  Picard Marceau; Simon Biron; Simon Marceau; Frederic-Simon Hould; Stefane Lebel; Odette Lescelleur; Laurent Biertho; John G Kral
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

4.  Advanced applications of robotics in digestive surgery.

Authors:  Alberto Patriti; Pietro Addeo; Nicolas Buchs; Luciano Casciola; Philippe Morel
Journal:  Transl Med UniSa       Date:  2011-10-17

5.  Perioperative Outcomes of Proximal and Distal Gastric Bypass in Patients with BMI Ranged 50-60 kg/m(2)--A Double-Blind, Randomized Controlled Trial.

Authors:  Marius Svanevik; Hilde Risstad; Dag Hofsø; Carl Fredrik Schou; Brita Solheim; Torgeir T Søvik; Jon Kristinsson; Jøran Hjelmesæth; Tom Mala; Rune Sandbu
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.